Teratogenic effects of carbamazepine on embryonic eye development in pregnant mice

Cutaneous and Ocular Toxicology

Volumn 29, Issue 1, 2010, Pages 10-15

  Afshar, Mohammad ^a   Moallem, Seyed Adel ^b,c,d   Houshang Mohammadpour, Amir ^b,c   Shiravi, Abdolhossein ^e   Majid Jalalian, Seyed ^e   Jafar Golalipour, Mohammad ^f  

^a BIRJAND UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^e ISLAMIC AZAD UNIVERSITY   (Iran)

^f GOLESTAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Carbamazepine; Mice; Ocular malformations; Pregnancy; Teratogenicity

Indexed keywords

CARBAMAZEPINE; POLYSORBATE 20; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BAGG ALBINO MOUSE; BRACHYDACTYLY; CESAREAN SECTION; CONTROL GROUP; CONTROLLED STUDY; CROWN RUMP LENGTH; EMBRYO; EMBRYO DEVELOPMENT; EXOPHTHALMOS; EXPERIMENTAL STUDY; EYE DEVELOPMENT; EYE MALFORMATION; FEMALE; FETUS; FETUS MALFORMATION; GESTATIONAL AGE; MOUSE; NONHUMAN; ORGANOGENESIS; PREGNANCY; RETINA FOLD; STAINING; TERATOGENESIS; VERTEBRA MALFORMATION;

ABNORMALITIES, DRUG-INDUCED; ABNORMALITIES, MULTIPLE; ANALGESICS, NON-NARCOTIC; ANIMALS; ANTICONVULSANTS; CARBAMAZEPINE; CROWN-RUMP LENGTH; EATING; EYE; EYE ABNORMALITIES; FEMALE; FETAL WEIGHT; GESTATIONAL AGE; INJECTIONS, INTRAPERITONEAL; MICE; MICE, INBRED BALB C; MUSCULOSKELETAL ABNORMALITIES; ORGANOGENESIS; PREGNANCY; RISK ASSESSMENT; TERATOGENS;

MUS;

EID: 77149137048     PISSN: 15569527     EISSN: 15569535     Source Type: Journal    
DOI: 10.3109/15569520903380353     Document Type: Article

References (23)

1. Hansen DK, Dial SL, Terry KK, Grafton TF. In vitro embryotoxicity of carbamazepine and carbamazepine-10, 11-epoxide. Teratology 1996;54(1):45-51.
2. Matalon S, Schechtman S, Goldzweig G, Ornoy A. The teratogenic effect of carbamazepine: a meta-analysis of 1255 exposures. Reprod Toxicol 2002;16(1):9-17.
3. Fritz H, Muller D, Hess R. Comparative study of the teratogenicity of phenobarbitone, diphenylhydantoin and carbamazepine in mice. Toxicology 1976;6:323-330
4. Artama M, Auvinen A, Raudaskoski T, Isojarvi I, Isojarvi J. Antiepileptic drug use of women with epilepsy and congenital malformations in offspring. Neurology 2005;64:1874-1878
5. Fahnehjelm KT, Wide K, Ygge J, Hellstrom A, Tomson T, Winbladh B, Stromland K. Visual and ocular outcome in children after prenatal exposure to antiepileptic drugs. Acta Ophthalmol Scand 1999;77:530-535
6. Sutcliffe AG, Jones RB, Woodruff G. Eye malformations associated with treatment with carbamazepine during pregnancy. Ophthalmic Genet 1998;19:59-62.
7. Kroes HY, Reefhuis J, Cornel MC. Is there an association between maternal carbamazepine use during pregnancy and eye malformations in the child?Epilepsia 2002;43:929-931
8. Inouye M. Differential staining of cartilage and bone in fetal mouse skeleton by alcian blue and alizarin red S. Congenit Anom 1976;16:171-173.
9. Kimmel CA, Trammell C. A rapid procedure for routine double staining of cartilage and bone in fetal and adult animals. Stain Technol 1981;56:271-273
10. Ornoy A, Cohen I. Follow-up studies of children born to epileptic women treated with carbamazepine. Teratology 1995;51:169.
11. Gladstone DJ, Bologa M, Maguire C, Pastuszak A, Koren G. Course of pregnancy and fetal outcome following maternal exposure to carbamazepine and phenytoin: a prospective study. Reprod Toxicol 1992;6:257-261
12. Ornoy A, Cohen E. Outcome of children born to epileptic mothers treated with carbamazepine during pregnancy. Arch Dis Child 1996;75:517-520
13. Diav-Citrin O, Shechtman S, Arnon J, Ornoy A. Is carbamazepine teratogenic? A prospective controlled study of 210 pregnancies. Neurology 2001;57:321-324
14. Holmes LB. The teratogenicity of anticonvulsant drugs: a progress report. J Med Genet 2002;39:245-247
15. Jones KL, Lacro RV, Johnson KA, Adams J. Pattern of malformations in the children of women treated with carbamazepine during pregnancy. N Engl J Med 1989;320:1661-1666
16. Piersma AH, Verhoef A, Opperhuizen A, Klaassen R, Van Eijkeren J, Olling M. Embryotoxicity of carbamazepine in rat postimplantation embryo culture after in vitro exposure via three different routes. Reprod Toxicol 1998;12:161-168
17. Calzolari E, Calabrese O, Cocchi G. Anophthalmia and situs viscerum inversus in an infant exposed to vigabatrin. Teratology 1997;56:397.
18. Arpino C, Brescianini S, Robert E, Castilla EE, Cocchi G, Cornel MC, et al. Teratogenic effects of antiepileptic drugs: use of an International Database on Malformations and Drug Exposure (MADRE). Epilepsia 2000;41:1436-1443
19. Vorhees CV, Acuff KD, Weisenburger WP, Minck DR. Teratogenicity of carbamazepine in rats. Teratology 1990;41:311-317
20. Lindhout D, Hoppener RJ, Meinardi H. Teratogenicity of antiepileptic drug combinations with special emphasis on epoxidation (of carbamazepine). Epilepsia 1984;25:77-83.
21. Bennett GD, Amore BM, Finnell RH, Wlodarczyk B, Kalhorn TF, Skiles GL, et al. Teratogenicity of carbamazepine-10, 11-epoxide and oxcarbazepine in the SWV mouse. J Pharmacol Exp Ther 1996;279:1237-1242
22. Murabe M, Yamauchi J, Fujiwara Y, Miyamoto Y, Hiroyama M, Sanbe A, et al. Estimation of the embryotoxic effect of CBZ using an ES cell differentiation system. Biochem Biophys Res Commun 2007;356:739-744 (Pubitemid 46499027)
23. Steinhoff BJ, Freudenthaler N, Paulus W. The influence of established and new antiepileptic drugs on visual perception. II. A controlled study in patients with epilepsy under long-term antiepileptic medication. Epilepsy Res 1997;29(1):49-58. (Pubitemid 27513001)